S. Meltzer

Beta agonists and asthma: how do new developments affect traditional therapy?

E. Bleecker, S. Meltzer, 1993, The Journal of asthma : official journal of the Association for the Care of Asthma.

Subjects with mild and moderate asthma respond to segmental allergen challenge with similar, reproducible, allergen-specific inflammation.

E. Bleecker, W. Moore, J. Hasday, 2001, The Journal of allergy and clinical immunology.

Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics.

E. Bleecker, L. Dubé, W. Moore, 2000, American journal of respiratory and critical care medicine.

Superoxide generation and its modulation by adenosine in the neutrophils of subjects with asthma.

S. Meltzer, J. Easton, B. Goldberg, 1989, The Journal of allergy and clinical immunology.

Dysregulation of airway cytokine expression in chronic obstructive pulmonary disease and asthma.

J. Hasday, K. A. McCrea, S. Meltzer, 1994, American journal of respiratory and critical care medicine.

The preclinical pharmacological profile of the potent and selective leukotriene B4 antagonist CP-195543.

M. Smith, A. Milici, E. Pettipher, 1998, The Journal of pharmacology and experimental therapeutics.

T-Cell repertoire in the blood and lungs of atopic asthmatics before and after ragweed challenge.

E. Bleecker, W. Moore, D. Postma, 1998, American journal of respiratory cell and molecular biology.

Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor.

E. Bleecker, J. Hasday, J. Cohn, 1996, American journal of respiratory and critical care medicine.